Download Program

Day 1: December 4, 2024

• 08:00–08:30 Registration & Refreshments

• 08:30 – 08:45 Welcome and introductions. Amir Seyedmousavi, Malcolm Richardson

Session 1. Chairs: John Bennett, Gary Procop

• 08:45–09:10 Case study 1: Why it’s important to know local epidemiology of fungal infections? John Bennett
• 09:10–09:35 Opportunistic fungal disease in normal and abnormal hosts, ICU patients, and children: underlying risk factors. John Perfect
• 09:35–10:00 Global burden of fungal diseases (updates on Latin America, African countries, Europe, and Asia). Malcolm Richardson
• 10:00–10:25 Importance of fungal identification to species level. June Kwon-Chung
• 10:25–10:40 Q&A

10:40–11:00 Comfort Break 

 Session 2. Chairs: Shawn Lockhart, Cornelia Lass-Flörl

• 11:00–11:25 Case study 2: Why is it important to collect specimens properly if fungal diseases are suspected? Juan Gea-Banacloche
• 11:25–11:50 Cytology and histopathology of Fungal Diseases. Gary Procop
• 11:50–12:15 Detection of Pneumocystis pneumonia in HIV associated and non-HIV patients. Riina Richardson
• 12:15–12:30 Q&A

12:30–13:30 Lunch

Session 3. Chairs: Paul Verweij, Malcolm Richardson

• 13:30–13:55 Case study 3: Fungal nomenclature (medically important fungi)-WHO fungal priority list, emerging fungal pathogens. Shawn Lockhart
• 13:55–14:20 Diagnostic work up for yeast infections. Maiken Arendrup
• 14:20–14:45 Diagnostic work up for mould infections. Cornelia Lass-Flörl
• 14:45–15:10 Diagnostic work up for dimorphic fungal infections. Nathan Wiederhold
• 15:10–15:25 Q&A 

15:25–15:45 Comfort Break

 Session 4. Chairs: Dimitrios Kontoyiannis, Maiken Arendrup

• 15:45–16:10 Case study 4: Fungal molecular testing, and how to use next-generation sequencing in diagnostic laboratories. Niaz Banaei
• 16:10– 16:35 Benefits and Limitations of MALDI-TOF for fungal identification. Darius Armstrong-James
• 16:35–17:00 Clinical sampling, Processing and Direct microscopic examination. Arunaloke Chakrabarti
• 17:0– 17:25 Fungal diagnostic assays that clinicians need in resource-limited countries. Rita Oladele
• 17:25–17:40 Q&A 

17:40–18:00 Closing Remarks. Amir Seyedmousavi, Malcolm Richardson

 Day 2: December 5, 2024

08:00–08:30 Welcome & Refreshments 

Session 5. Chairs: Mihalis Lionakis, John Perfect

• 08:30–08:55 Case study 5: Antifungal host defenses. Steven Holland
• 08:55–09:20 Antifungals and their mechanisms of action: currently available and new antifungal drugs. Mihalis Lionakis
• 09:20–09:45 Antifungal susceptibility testing (EUCAST versus CLSI). Nathan Wiederhold
• 09:45–10:10 Mechanism of antifungal resistance in yeasts and currently available phenotypic and genotyping laboratory assays. Mahmoud Ghannoum
• 10:10–10:35 Mechanism of antifungal resistance in molds and currently available phenotypic and genotyping laboratory assays. Paul Verweij
• 10:35–10:50 Q&A

10:50–11:10 Comfort Break

Session 6: Chairs: Juan Gea-Banacloche, Riina Richardson  

• 11:10–11:35 Case study 6: Fungal disease laboratory screening and infection prevention: why, when, where, and how? Amir Seyedmousavi
• 11:35–12:00 Testing for Candida auris colonization screening. Philippe Dufresne
• 12:00–12:25 Infection prevention for zoonotic dimorphs and other emerging fungal disease. Flavio Queiroz Telles
• 12:25–12:40 Q&A

12:40–13:30 Lunch 

Session 7. Chairs: Flavio De Queiroz Telles Filho, Kieren Marr

• 13:30–13:55 Case study 7: A clinician’s view of point of care diagnostics for invasive mold disease: promises, challenges, and prospects. Dimitrios Kontoyiannis
• 13:55–14:20 Serodiagnosis of histoplasmosis, blastomycosis and coccidioides infection. Joe Wheat
• 14:20– 14:45 non-culture-based diagnosis of Aspergillus vs. Candida infections. Martin Hönigl
• 14:45–15:10 Cryptococcosis antigen detection. Masoud Mardani
• 15:10–15:25 Q&A 

15:25 – 15:45 Comfort Break

 Session 8. Chairs: Arunaloke Chakrabarti, Darius Armstrong-James

• 15:45–16:10 Case study 8: Fungal cell-free DNA (cfDNA) detection. Niaz Banaei
• 16:10–16:35 Non-invasive surrogate markers under development. Kieren Marr
• 16:35–17:00 Evolution of fungal diagnostics for clinical microbiology applications. What's new? Hari DWIVEDI
• 17:00–17:15 Q&A 

17:15–18:00 Closing Remarks and Certification Ceremony. Amir Seyedmousavi, Malcolm Richardson

ISHAM-Fungal Dx 2024 will start at 8.00 AM on Wednesday 4 December 2024 and will end on Thursday 5 December 2024 at 6.00 PM. 

 The workshop language will be English.